Eyepoint Pharmaceuticals, Inc. (EYPT) — DEFA14A Filings
All DEFA14A filings from Eyepoint Pharmaceuticals, Inc.. Browse 1 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (1)
-
EyePoint Pharma Files Proxy Statement Amendment
— May 9, 2025 Risk: low
EyePoint Pharmaceuticals, Inc. filed an amendment (Amendment No. 1) to its Definitive Proxy Statement (DEFA14A) on May 9, 2025. This filing concerns the solicit
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX